HIV As a Risk Factor for Lung Cancer in Women: Data from the Women's Interagency HIV Study

Overview

Journal J Clin Oncol

Specialty Oncology

Date 2010 Feb 24

PMID 20177022

Citations 27

Authors

Alexandra M Levine

Eric C Seaberg

Nancy A Hessol

Susan Preston-Martin

Sylvia Silver

Mardge H Cohen

Kathryn Anastos

Howard Minkoff

Jan Orenstein

Geraldina Dominguez

D Heather Watts

Affiliations

Soon will be listed here.

Abstract

Purpose: Prior reports of an increased risk of lung cancer in HIV-infected individuals have not always included control groups, nor considered other risk factors such as tobacco exposure. We sought to determine the role of HIV infection and highly active antiretroviral therapy (HAART) on lung cancer incidence in 2,651 HIV-infected and 898 HIV-uninfected women from the Women's Interagency HIV Study (WIHS).

Methods: A prospective study of the incidence rates of lung cancer was conducted, with cases identified through medical records, death certificates, and state cancer registries. Standardized incidence ratios (SIRs) were calculated to compare lung cancer incidence among HIV-infected and uninfected WIHS participants, with population-based expectations using the Surveillance, Epidemiology, and End Results registry. Behavioral characteristics in the WIHS were compared to US women by age and race adjusting the population-based data from the National Health and Nutritional Examination Survey (NHANES) III.

Results: Incidence rates of lung cancer were similar among HIV-infected and uninfected WIHS women. Lung cancer SIRs were increased in both HIV-infected and -uninfected women compared with population expectations, but did not differ by HIV status. Among HIV-infected women, lung cancer incidence rates were similar in pre-HAART and HAART eras. All WIHS women with lung cancer were smokers; the risk of lung cancer increased with cumulative tobacco exposure. WIHS women were statistically more likely to smoke than US women studied in NHANES III.

Conclusion: HIV infection is strongly associated with smoking behaviors that increase lung cancer risk. The role of HIV itself remains to be clarified.

Citing Articles

The PD-1 single-nucleotide polymorphism rs11568821 and rs2227981 as a novel prognosis model in a triple-negative breast cancer patient.

Boguszewska-Byczkiewicz K, Wow T, Szymanska B, Kosny M, Kolacinska-Wow A Mol Biol Rep. 2023; 50(7):6279-6285.

PMID: 37212960 DOI: 10.1007/s11033-023-08423-3.

Incidence and mortality of non-AIDS-defining cancers among people living with HIV: A systematic review and meta-analysis.

Yuan T, Hu Y, Zhou X, Yang L, Wang H, Li L EClinicalMedicine. 2022; 52:101613.

PMID: 35990580 PMC: 9386399. DOI: 10.1016/j.eclinm.2022.101613.

HIV and cancer in the Veterans Health Administration System.

Sigel K, Park L, Justice A Semin Oncol. 2019; 46(4-5):334-340.

PMID: 31703932 PMC: 7071926. DOI: 10.1053/j.seminoncol.2019.09.007.

Are Non-HIV Malignancies Increased in the HIV-Infected Population?.

Thrift A, Chiao E Curr Infect Dis Rep. 2018; 20(8):22.

PMID: 29804238 PMC: 9392463. DOI: 10.1007/s11908-018-0626-9.

Cancer screening in women living with HIV infection.

Aboulafia D Womens Health (Lond). 2017; 13(3):68-79.

PMID: 28952428 PMC: 7789029. DOI: 10.1177/1745505717731970.

References

Kirk G, Merlo C, O Driscoll P, Mehta S, Galai N, Vlahov D . HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis. 2007; 45(1):103-10. PMC: 4078722. DOI: 10.1086/518606. View

Vyzula R, Remick S . Lung cancer in patients with HIV-infection. Lung Cancer. 1996; 15(3):325-39. DOI: 10.1016/0169-5002(95)00596-x. View

Karp J, Profeta G, Marantz P, Karpel J . Lung cancer in patients with immunodeficiency syndrome. Chest. 1993; 103(2):410-3. DOI: 10.1378/chest.103.2.410. View

Palella Jr F, Delaney K, Moorman A, Loveless M, Fuhrer J, Satten G . Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998; 338(13):853-60. DOI: 10.1056/NEJM199803263381301. View

Brock M, Hooker C, Engels E, Moore R, Gillison M, Alberg A . Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: implications for patient care. J Acquir Immune Defic Syndr. 2006; 43(1):47-55. DOI: 10.1097/01.qai.0000232260.95288.93. View

Engels E, Brock M, Chen J, Hooker C, Gillison M, Moore R . Elevated incidence of lung cancer among HIV-infected individuals. J Clin Oncol. 2006; 24(9):1383-8. DOI: 10.1200/JCO.2005.03.4413. View

Tirelli U, Spina M, Sandri S, Serraino D, Gobitti C, Fasan M . Lung carcinoma in 36 patients with human immunodeficiency virus infection. The Italian Cooperative Group on AIDS and Tumors. Cancer. 2000; 88(3):563-9. DOI: 10.1002/(sici)1097-0142(20000201)88:3<563::aid-cncr11>3.0.co;2-d. View

Bower M, Powles T, Nelson M, Shah P, Cox S, Mandelia S . HIV-related lung cancer in the era of highly active antiretroviral therapy. AIDS. 2003; 17(3):371-5. DOI: 10.1097/00002030-200302140-00011. View

. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst. 2000; 92(22):1823-30. DOI: 10.1093/jnci/92.22.1823. View

10.

Hessol N, Seaberg E, Preston-Martin S, Massad L, Sacks H, Silver S . Cancer risk among participants in the women's interagency HIV study. J Acquir Immune Defic Syndr. 2004; 36(4):978-85. DOI: 10.1097/00126334-200408010-00013. View

11.

Herida M, Mary-Krause M, Kaphan R, Cadranel J, Poizot-Martin I, Rabaud C . Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol. 2003; 21(18):3447-53. DOI: 10.1200/JCO.2003.01.096. View

12.

Powles T, Thirwell C, Newsom-Davis T, Nelson M, Shah P, Cox S . Does HIV adversely influence the outcome in advanced non-small-cell lung cancer in the era of HAART?. Br J Cancer. 2003; 89(3):457-9. PMC: 2394391. DOI: 10.1038/sj.bjc.6601111. View

13.

Alshafie M, Donaldson B, Oluwole S . Human immunodeficiency virus and lung cancer. Br J Surg. 1997; 84(8):1068-71. View

14.

Bazot M, Cadranel J, Khalil A, Benayoun S, Milleron B, Bigot J . Computed tomographic diagnosis of bronchogenic carcinoma in HIV-infected patients. Lung Cancer. 2000; 28(3):203-9. DOI: 10.1016/s0169-5002(99)00124-5. View

15.

Bacon M, von Wyl V, Alden C, Sharp G, Robison E, Hessol N . The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol. 2005; 12(9):1013-9. PMC: 1235804. DOI: 10.1128/CDLI.12.9.1013-1019.2005. View

16.

Mbulaiteye S, Biggar R, Goedert J, Engels E . Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr. 2003; 32(5):527-33. DOI: 10.1097/00126334-200304150-00010. View

17.

Grulich A, Li Y, McDonald A, Correll P, Law M, Kaldor J . Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS. 2002; 16(8):1155-61. DOI: 10.1097/00002030-200205240-00009. View

18.

Barkan S, Melnick S, Preston-Martin S, Weber K, Kalish L, Miotti P . The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology. 1998; 9(2):117-25. View

19.

Saves M, Chene G, Ducimetiere P, Leport C, Le Moal G, Amouyel P . Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. Clin Infect Dis. 2003; 37(2):292-8. DOI: 10.1086/375844. View

20.

Phelps R, Smith D, Heilig C, GARDNER L, CARPENTER C, Klein R . Cancer incidence in women with or at risk for HIV. Int J Cancer. 2001; 94(5):753-7. DOI: 10.1002/ijc.1528. View